Mark E. Schmidt
About
Mark E. Schmidt is a scholar working on Psychiatry and Mental health, Radiology, Nuclear Medicine and Imaging and Molecular Biology.
According to data from OpenAlex, Mark E. Schmidt has authored 126 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Psychiatry and Mental health, 41 papers in Radiology, Nuclear Medicine and Imaging and 30 papers in Molecular Biology. Recurrent topics in Mark E. Schmidt's work include Medical Imaging Techniques and Applications (28 papers), Alzheimer's disease research and treatments (22 papers) and Dementia and Cognitive Impairment Research (19 papers). Mark E. Schmidt is often cited by papers focused on Medical Imaging Techniques and Applications (28 papers), Alzheimer's disease research and treatments (22 papers) and Dementia and Cognitive Impairment Research (19 papers). Mark E. Schmidt collaborates with scholars based in United States, Belgium and United Kingdom. Mark E. Schmidt's co-authors include William J. Jagust, Holly Soares, Michael W. Weiner, Clifford R. Jack, Andrew J. Saykin, John C. Morris, Laurel Beckett, John Q. Trojanowski, Robert C. Green and Leslie M. Shaw and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Chemical Physics and Physical review. B, Condensed matter.
In The Last Decade
Mark E. Schmidt
122 papers receiving 4.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mark E. Schmidt United States | 32 | 1.4k | 1.2k | 1.1k | 942 | 898 | 126 | 4.8k | ||
| Mathieu Vandenbulcke Belgium | 43 | 1.6k 1.1× | 1.3k 1.0× | 572 0.5× | 523 0.6× | 1.4k 1.6× | 190 | 5.2k | ||
| Piero Antuono United States | 33 | 1.3k 0.9× | 1.0k 0.8× | 746 0.7× | 469 0.5× | 1.7k 1.9× | 84 | 4.3k | ||
| Richard Hargreaves United States | 46 | 1.7k 1.2× | 1.6k 1.3× | 1.9k 1.8× | 2.0k 2.1× | 862 1.0× | 152 | 6.8k | ||
| Fumihiko Yasuno Japan | 35 | 1.2k 0.8× | 769 0.6× | 768 0.7× | 1.9k 2.0× | 1.0k 1.1× | 119 | 4.6k | ||
| Bradley T. Christian United States | 39 | 1.5k 1.0× | 1.3k 1.1× | 793 0.7× | 816 0.9× | 1.2k 1.3× | 194 | 4.8k | ||
| Johannes Pantel Germany | 44 | 2.0k 1.4× | 2.0k 1.6× | 825 0.8× | 410 0.4× | 1.5k 1.6× | 219 | 5.4k | ||
| Akihiro Takano Japan | 38 | 1.0k 0.7× | 487 0.4× | 960 0.9× | 1.7k 1.8× | 889 1.0× | 175 | 4.7k | ||
| Daniel P. Holt United States | 29 | 1.4k 1.0× | 2.3k 1.9× | 1.1k 1.1× | 991 1.1× | 794 0.9× | 98 | 5.4k | ||
| Adam J. Schwarz United States | 42 | 1.0k 0.7× | 1.2k 1.0× | 705 0.7× | 1.3k 1.4× | 2.7k 3.0× | 130 | 5.7k | ||
| Jean C. Augustinack United States | 33 | 1.3k 0.9× | 1.5k 1.3× | 770 0.7× | 1.1k 1.1× | 2.6k 2.9× | 75 | 6.0k |
Countries citing papers authored by Mark E. Schmidt
Since
Specialization
Citations
This map shows the geographic impact of Mark E. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Schmidt more than expected).
Fields of papers citing papers by Mark E. Schmidt
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Mark E. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Schmidt. The network helps show where Mark E. Schmidt may publish in the future.
Co-authorship network of co-authors of Mark E. Schmidt
This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Schmidt. A scholar is included among the top collaborators of Mark E. Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Schmidt. Mark E. Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Klein, Matthew, Abigail Bangerter, Robin Halter, et al.. (2024). Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study. Neuropsychopharmacology. 50(2). 480–487.
2.
Mastenbroek, Sophie E, Arianna Sala, Juan Domingo Gispert, et al.. (2023). Biological and methodological factors underlying a continuous amyloid CSF/PET imbalance model and its association with longitudinal cognition. Alzheimer s & Dementia. 19(S10).
3.
Markiewicz, Paweł, Julian C. Matthews, John Ashburner, et al.. (2021). Uncertainty analysis of MR-PET image registration for precision neuro-PET imaging. NeuroImage. 232. 117821–117821.
4.
Waldron, Ann‐Marie, Leonie Wyffels, Jeroen Verhaeghe, et al.. (2016). Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model. Journal of Alzheimer s Disease. 55(4). 1537–1548.
5.
Waldron, Ann‐Marie, Leonie Wyffels, Jeroen Verhaeghe, et al.. (2015). Quantitative μPET Imaging of Cerebral Glucose Metabolism and Amyloidosis in the TASTPM Double Transgenic Mouse Model of Alzheimer’s Disease. Current Alzheimer Research. 12(7). 694–703.
6.
Ooms, Maarten, Sofie Celen, Michel Koole, et al.. (2014). Synthesis and biological evaluation of carbon-11 and fluorine-18 labeled tracers for in vivo visualization of PDE10A. Nuclear Medicine and Biology. 41(8). 695–704.
7.
Pich, Emilio Merlo, Andreas Jeromin, Giovanni B. Frisoni, et al.. (2014). Imaging as a biomarker in drug discovery for Alzheimer’s disease: is MRI a suitable technology?. Alzheimer s Research & Therapy. 6(4). 51–51.
8.
Koole, Michel, Guy Bormans, Jan de Hoon, et al.. (2012). Tracer kinetic modeling of [C-11]JNJ42491293, a PET ligand for the mGluR2 receptor in the human brain. Journal of Cerebral Blood Flow & Metabolism. 32.
9.
Anghelescu, Ion‐George, Luc Janssens, Justine Kent, et al.. (2012). Does early improvement predict response to the fast-dissociating D2 receptor antagonist JNJ-37822681 in patients with acute schizophrenia? ☆. European Neuropsychopharmacology. 23(9). 1043–1050.
10.
Cole, Patricia E., Adam J. Schwarz, & Mark E. Schmidt. (2012). Applications of Imaging Biomarkers in the Early Clinical Development of Central Nervous System Therapeutic Agents. Clinical Pharmacology & Therapeutics. 91(2). 315–320.
11.
Celen, Sofie, Meri De Angelis, Michel Koole, et al.. (2011). [F-18]JNJ42259152 as potential radioligand for positron emission tomography imaging of phosphodiesterase-10A in the brain. Journal of Labelled Compounds and Radiopharmaceuticals. 54.
12.
Weiner, Michael W., Dallas P. Veitch, Paul Aisen, et al.. (2011). The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimer s & Dementia. 8(1S). S1–68.
13.
Schmidt, Mark E., Eric Siemers, Peter J. Snyder, et al.. (2010). The Alzheimer's Disease Neuroimaging Initiative: Perspectives of the Industry Scientific Advisory Board. Alzheimer s & Dementia. 6(3). 286–290.
14.
Celen, Sofie, Michel Koole, Meri De Angelis, et al.. (2010). Preclinical Evaluation of 18F-JNJ41510417 as a Radioligand for PET Imaging of Phosphodiesterase-10A in the Brain. Journal of Nuclear Medicine. 51(10). 1584–1591.
15.
Celen, Sofie, Meri De Angelis, Satish K. Chitneni, et al.. (2009). Synthesis and preliminary biological evaluation of [F-18]JNJ41510417as a radioligand for positron emission tomography imaging of phosphodiesterase-10A in the brain. European Journal of Nuclear Medicine and Molecular Imaging. 36.
16.
Schmidt, Mark E., Randolph D. Andrews, Peter van der Ark, et al.. (2009). Dose-dependent effects of the CRF1 receptor antagonist R317573 on regional brain activity in healthy male subjects. Psychopharmacology. 208(1). 109–119.
17.
Henry, Michael, et al.. (2001). The Effects of ECT on Brain Glucose: A Pilot FDG PET Study. Journal of Ect. 17(1). 33–40.
18.
Schmidt, Mark E., Maurizio Fava, James M. Robinson, & Rajinder Judge. (2000). The Efficacy and Safety of a New Enteric-Coated Formulation of Fluoxetine Given Once Weekly During the Continuation Treatment of Major Depressive Disorder. The Journal of Clinical Psychiatry. 61(11). 851–857.
19.
Potter, William Z. & Mark E. Schmidt. (1997). Treatment of Major Depression: Selection of Initial Drug. PubMed. 25. 1–16.
20.
Rapaport, Mark Hyman, et al.. (1994). The effects of prolonged lithium exposure on the immune system of normal control subjects: Serial serum soluble interleukin-2 receptor and antithyroid antibody measurements. Biological Psychiatry. 35(10). 761–766.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Mathieu Vandenbulcke Breakdown of academic impact, for papers by Piero Antuono Breakdown of academic impact, for papers by Richard Hargreaves Breakdown of academic impact, for papers by Fumihiko Yasuno Breakdown of academic impact, for papers by Bradley T. Christian Breakdown of academic impact, for papers by Johannes Pantel Breakdown of academic impact, for papers by Akihiro Takano Breakdown of academic impact, for papers by Daniel P. Holt Breakdown of academic impact, for papers by Adam J. Schwarz Breakdown of academic impact, for papers by Jean C. Augustinack